HK1255969A1 - 具有不依賴於ph釋放的軟膠囊 - Google Patents

具有不依賴於ph釋放的軟膠囊

Info

Publication number
HK1255969A1
HK1255969A1 HK18115043.5A HK18115043A HK1255969A1 HK 1255969 A1 HK1255969 A1 HK 1255969A1 HK 18115043 A HK18115043 A HK 18115043A HK 1255969 A1 HK1255969 A1 HK 1255969A1
Authority
HK
Hong Kong
Prior art keywords
gelatin capsules
soft gelatin
independent release
independent
release
Prior art date
Application number
HK18115043.5A
Other languages
English (en)
Inventor
Simone Carucci
Maurizio Marchiorri
Marco Pontiggia
Tiziano Fossati
Original Assignee
Altergon Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altergon Sa filed Critical Altergon Sa
Publication of HK1255969A1 publication Critical patent/HK1255969A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18115043.5A 2015-12-09 2018-11-23 具有不依賴於ph釋放的軟膠囊 HK1255969A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITUB2015A006821A ITUB20156821A1 (it) 2015-12-09 2015-12-09 CAPSULE DI GELATINA MOLLE A RILASCIO pH INDIPENDENTE
PCT/EP2016/078913 WO2017097612A1 (en) 2015-12-09 2016-11-25 SOFT GELATIN CAPSULES WITH pH-INDEPENDENT RELEASE

Publications (1)

Publication Number Publication Date
HK1255969A1 true HK1255969A1 (zh) 2019-09-06

Family

ID=55588401

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18115043.5A HK1255969A1 (zh) 2015-12-09 2018-11-23 具有不依賴於ph釋放的軟膠囊

Country Status (9)

Country Link
US (1) US11304910B2 (zh)
EP (1) EP3386489B1 (zh)
CN (1) CN108366971A (zh)
CA (1) CA3007592A1 (zh)
DK (1) DK3386489T3 (zh)
HK (1) HK1255969A1 (zh)
IT (1) ITUB20156821A1 (zh)
RU (1) RU2738933C2 (zh)
WO (1) WO2017097612A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3311844A1 (en) 2016-10-18 2018-04-25 Altergon S.A. High-stability packaged solutions of t4 thyroid hormone
CN108938588B (zh) * 2018-08-16 2021-06-22 广州维奥康药业科技有限公司 一种依折麦布片
US11241382B2 (en) 2019-03-01 2022-02-08 Altergon Sa Administration regimen of compositions of T4 thyroid hormone with high oral absorption
CA3159407A1 (en) * 2019-10-28 2021-05-06 R.P. Scherer Technologies, Llc Delayed release softgel capsules in higher ph environment
CN112826807B (zh) * 2021-01-29 2022-10-04 北京航洋健康科技有限公司 一种软胶囊囊壳及由其制备的软胶囊及其制备方法
WO2023167803A1 (en) * 2022-03-01 2023-09-07 Sittner Edward Oscar Method of manufacture of active ingredient infused gelatin capsule

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8305693D0 (en) * 1983-03-02 1983-04-07 Scherer Ltd R P Pharmaceutical compositions
US4795642A (en) * 1986-05-01 1989-01-03 Pharmacaps, Inc. Gelatin-encapsulated controlled-release composition
US4708834A (en) * 1986-05-01 1987-11-24 Pharmacaps, Inc. Preparation of gelatin-encapsulated controlled release composition
US5102666A (en) * 1990-09-11 1992-04-07 Oramed, Inc. Calcium polycarbophil controlled release composition and method
EP0725626A1 (en) * 1993-10-29 1996-08-14 RECKITT & COLMAN PRODUCTS LIMITED Gelatin capsule fill able to foam
WO1999022768A1 (en) * 1997-10-31 1999-05-14 Monsanto Company Controlled release compositions comprising gellan gum gels
EP1184033A1 (en) * 2000-09-01 2002-03-06 Warner-Lambert Company Pectin film compositions
ITMI20011401A1 (it) * 2001-07-02 2003-01-02 Altergon Sa Formulazioni farmaceutiche per ormoni tiroidei
US20070098784A1 (en) * 2001-09-28 2007-05-03 Nutraceutix, Inc. Delivery system for biological component
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
CN100335134C (zh) * 2005-10-26 2007-09-05 中国药科大学 尼莫地平软胶囊及其制备方法
US20070148248A1 (en) * 2005-12-22 2007-06-28 Banner Pharmacaps, Inc. Gastric reflux resistant dosage forms
US20080107779A1 (en) * 2006-11-06 2008-05-08 Sara Lee Corporation Pancrepe and method of making same
EP2222183A4 (en) * 2007-11-20 2014-02-19 Intercontinental Great Brands Llc DOUBLE COATED CONFECTIONERY PRODUCT
WO2009126742A2 (en) * 2008-04-08 2009-10-15 Appian Labs, Llc Enzyme mediated delivery system
KR20090131256A (ko) * 2008-06-17 2009-12-28 주식회사파마펙스 함습 억제 및 방출속도 조절을 위한 생약추출물 함유 서방성 제제
CN102342963B (zh) * 2011-10-19 2013-07-10 西安大唐制药集团有限公司 一种肝苏软胶囊的制备工艺
CN103860732A (zh) * 2014-04-10 2014-06-18 西安大唐制药集团有限公司 一种复方益肝灵软胶囊的制备方法

Also Published As

Publication number Publication date
CN108366971A (zh) 2018-08-03
EP3386489B1 (en) 2024-09-11
RU2738933C2 (ru) 2020-12-18
DK3386489T3 (da) 2024-09-23
US20180353432A1 (en) 2018-12-13
EP3386489A1 (en) 2018-10-17
WO2017097612A1 (en) 2017-06-15
RU2018120693A3 (zh) 2020-03-04
US11304910B2 (en) 2022-04-19
CA3007592A1 (en) 2017-06-15
ITUB20156821A1 (it) 2017-06-09
RU2018120693A (ru) 2020-01-10

Similar Documents

Publication Publication Date Title
ZA201708561B (en) Microcapsules
AU365267S (en) Ring
TWD174458S (zh) 戒指
ZA201703444B (en) Calcifediol soft capsules
HK1255969A1 (zh) 具有不依賴於ph釋放的軟膠囊
GB201417067D0 (en) Radiopharmaceutical conjugate
GB201608157D0 (en) Capsules
IL266022A (en) Capsule with controlled release
HK1253677A1 (zh) 緩釋薄膜包衣膠囊
SG11201701972PA (en) Soft capsule shell
GB2547028B (en) Early connection release
HK1215385A1 (zh) 改進釋放的被覆蓋的膠囊
SG11201800516TA (en) Enteric capsule
SG10201605127UA (en) Theater seating
SI3145499T1 (sl) Obložene kapsule s prirejenim sproščanjem
ZA201800184B (en) Extended release capecitabine capsules
IL259959A (en) Oxygen-generating capsule
IL273766A (en) Portion capsule
HK1202255A1 (zh) 種別嘌醇緩釋膠囊及其製備方法
GB201716001D0 (en) EG tipex etc capsules
GB201509538D0 (en) Hellum capsules
GB201517042D0 (en) T Shells
AU201613163S (en) Ring
AU362816S (en) Capsule
GB201517946D0 (en) Softgel